COGT · Cogent Biosciences, Inc.
$37.93
+0.62 (+1.66%)
At close · Aug 14
Market Cap
$6.58B
Shares
173.52M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-31 | Fairmount Healthcare Fund II L.P. | Director | 7,000,000 | 2026-03-31 | Goldman Sachs & Co. LLC |
| 2026-01-22 | Fairmount Healthcare Fund II L.P. | Director | 3,500,000 | 2026-01-22 | Jefferies LLC |
| 2025-12-29 | JOHN GREEN | Officer | 77,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | JOHN ROBINSON | Officer | 90,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | EVAN D KEARNS | Officer | 65,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | JESSICA SACHS | Officer | 82,642 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–6 of 6 filings
Key facts
CIK
1622229
CUSIP
19240Q201
13F (30d)
312 filings
308 filers
Visit website
Investor relations